A carregar...
Receptor Discordance of Metastatic Breast Cancer Depending on the Molecular Subtype
INTRODUCTION: Almost 30% of all women with early-stage breast cancer develop metastases. Treatment of metastatic disease is often based on the immunohistochemical information of the primary tumor, despite possible discordance of the hormone and Her2 receptor status. OBJECTIVES: The aim of this study...
Na minha lista:
| Publicado no: | Breast Care (Basel) |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
S. Karger GmbH
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7768158/ https://ncbi.nlm.nih.gov/pubmed/33447240 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000506464 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|